Paolo Campisi

Paolo Campisi

Auto-generated profile, based on publicly available information

Paolo Campisi

Hospital for Sick Children, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2020 in Medical Teacher
Verified
Journal Article
Closed access
AHAndrew K. Hall
Andrew K. Hall
MNMarkku T. Nousiainen
Markku T. Nousiainen
PCPaolo Campisi
Paolo Campisi
JDJ. Damon Dagnone
J. Damon Dagnone
JFJason R. Frank
Jason R. Frank
AOAnna Oswald
Anna Oswald
The COVID-19 pandemic has disrupted healthcare systems around the world, impacting how we deliver medical education. The normal day-to-day routines have been altered for a number of reasons, including changes to scheduled training rotations, physical distancing requirements, trainee redeployment, and heightened level of concern. Medical educators will likely need to adapt their programs to maximize learning, maintain effective care delivery, and ensure competent graduates. Along with a continued focus on learner/faculty wellness, medical educators will have to optimize existing training experiences, adapt those that are no longer viable, employ new technologies, and be flexible when assessing competencies. These practical tips offer guidance on how to adapt medical education programs within the constraints of the pandemic landscape, stressing the need for communication, innovation, collaboration, flexibility, and planning within the era of competency-based medical education.

21 May 2010 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
PCPaolo Campisi
Paolo Campisi
MHMichael T. Hawkes
Michael T. Hawkes
KSKim Simpson
Kim Simpson
CGCanadian Juvenile Onset Recurrent Respiratory Papillomatosis Working Group
Canadian Juvenile Onset Recurrent Respiratory Papillomatosis Working Group

1 June 2016 in Seminars in Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
PCPaolo Campisi
Paolo Campisi
VFVito Forte
Vito Forte

17 September 2021 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ASAna Stosic
Ana Stosic
FFFabio Fuligni
Fabio Fuligni
NANathaniel D. Anderson
Nathaniel D. Anderson
SDScott Davidson
Scott Davidson
RBRichard de Borja
Richard de Borja
JWJonathan D. Wasserman
Jonathan D. Wasserman
Pediatric papillary thyroid carcinoma (PPTC) is clinically distinct from adult-onset disease. Although there are higher rates of metastasis and recurrence in PPTC, prognosis remains highly favorable. Molecular characterization of PPTC has been lacking. Historically, only 40% to 50% of childhood papillary thyroid carcinoma (PTC) were known to be driven by genomic variants common to adult PTC; oncogenic drivers in the remainder were unknown. This contrasts with approximately 90% of adult PTC driven by a discrete number of variants. In this study, 52 PPTCs underwent candidate gene testing, followed in a subset by whole-exome and transcriptome sequencing. Within these samples, candidate gene testing identified variants in 31 (60%) tumors, while exome and transcriptome sequencing identified oncogenic variants in 19 of 21 (90%) remaining tumors. The latter were enriched for oncogenic fusions, with 11 nonrecurrent fusion transcripts, including two previously undescribed fusions, STRN-RET and TG-PBF. Most fusions were associated with 3′ receptor tyrosine kinase (RTK) moieties: RET, MET, ALK, and NTRK3. For advanced (distally metastatic) tumors, a driver variant was described in 91%. Gene expression analysis defined three clusters that demonstrated distinct expression of genes involved in thyroid differentiation and MAPK signaling. Among RET-CCDC6–driven tumors, gene expression in pediatric tumors was distinguishable from that in adults. Collectively, these results show that the genomic landscape of pediatric PTC is different from adult PTC. Moreover, they identify genomic drivers in 98% of PPTCs, predominantly oncogenic fusion transcripts involving RTKs, with a pronounced impact on gene expression. Notably, most advanced tumors were driven by a variant for which targeted systemic therapy exists.Significance: This study highlights important distinctions between the genomes and transcriptomes of pediatric and adult papillary thyroid carcinoma, with implications for understanding the biology, diagnosis, and treatment of advanced disease in children.

6 January 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DSDouglas R. Sidell
Douglas R. Sidell
KBKarthik Balakrishnan
Karthik Balakrishnan
SBSimon R. Best
Simon R. Best
KZKaren Zur
Karen Zur
JBJulia Buckingham
Julia Buckingham
CDCraig S. Derkay
Craig S. Derkay

18 April 2011 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
WKWaqas Ullah Khan
Waqas Ullah Khan
PCPaolo Campisi
Paolo Campisi
SNSanjeevan Nadarajah
Sanjeevan Nadarajah
YSYaseer Abdul Shakur
Yaseer Abdul Shakur
NKNasir Khan
Nasir Khan
BCBairbre Connolly
Bairbre Connolly
Sialorrhea is defined as the involuntary, passive pooling and spillage of saliva from the mouth due to the inability to process oral secretions. Although it is common in children who have not developed oral neuromuscular control (younger than 24 months), drooling in individuals 4 years or older is considered abnormal.1-4 Patients with neurologic disorders such as Bell palsy, mental retardation, and cerebral palsy often experience excessive drooling.5 In children diagnosed as having cerebral palsy, it is estimated that 10% to 37% have sialorrhea.5,6